Literature DB >> 32167743

Use of EpiAlveolar Lung Model to Predict Fibrotic Potential of Multiwalled Carbon Nanotubes.

Hana Barosova1, Anna G Maione2, Dedy Septiadi1, Monita Sharma3, Laetitia Haeni1, Sandor Balog1, Olivia O'Connell2, George R Jackson2, David Brown4, Amy J Clippinger3, Patrick Hayden2,5, Alke Petri-Fink1,6, Vicki Stone4, Barbara Rothen-Rutishauser1.   

Abstract

Expansion in production and commercial use of nanomaterials increases the potential human exposure during the lifecycle of these materials (production, use, and disposal). Inhalation is a primary route of exposure to nanomaterials; therefore it is critical to assess their potential respiratory hazard. Herein, we developed a three-dimensional alveolar model (EpiAlveolar) consisting of human primary alveolar epithelial cells, fibroblasts, and endothelial cells, with or without macrophages for predicting long-term responses to aerosols. Following thorough characterization of the model, proinflammatory and profibrotic responses based on the adverse outcome pathway concept for lung fibrosis were assessed upon repeated subchronic exposures (up to 21 days) to two types of multiwalled carbon nanotubes (MWCNTs) and silica quartz particles. We simulate occupational exposure doses for the MWCNTs (1-30 μg/cm2) using an air-liquid interface exposure device (VITROCELL Cloud) with repeated exposures over 3 weeks. Specific key events leading to lung fibrosis, such as barrier integrity and release of proinflammatory and profibrotic markers, show the responsiveness of the model. Nanocyl induced, in general, a less pronounced reaction than Mitsui-7, and the cultures with human monocyte-derived macrophages (MDMs) showed the proinflammatory response at later time points than those without MDMs. In conclusion, we present a robust alveolar model to predict inflammatory and fibrotic responses upon exposure to MWCNTs.

Entities:  

Keywords:  air−liquid interface; human primary cells; long-term repeated exposures; lung model; multiwalled carbon nanotubes; pulmonary fibrosis

Year:  2020        PMID: 32167743     DOI: 10.1021/acsnano.9b06860

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  8 in total

Review 1.  Overview of Adverse Outcome Pathways and Current Applications on Nanomaterials.

Authors:  Dora Rolo; Ana Tavares; Nádia Vital; Maria João Silva; Henriqueta Louro
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 2.  Recent Advances in Molecular Diagnosis of Pulmonary Fibrosis for Precision Medicine.

Authors:  Mi Ho Jeong; Hongwei Han; David Lagares; Hyungsoon Im
Journal:  ACS Pharmacol Transl Sci       Date:  2022-07-20

3.  In silico approaches in organ toxicity hazard assessment: Current status and future needs for predicting heart, kidney and lung toxicities.

Authors:  Arianna Bassan; Vinicius M Alves; Alexander Amberg; Lennart T Anger; Lisa Beilke; Andreas Bender; Autumn Bernal; Mark T D Cronin; Jui-Hua Hsieh; Candice Johnson; Raymond Kemper; Moiz Mumtaz; Louise Neilson; Manuela Pavan; Amy Pointon; Julia Pletz; Patricia Ruiz; Daniel P Russo; Yogesh Sabnis; Reena Sandhu; Markus Schaefer; Lidiya Stavitskaya; David T Szabo; Jean-Pierre Valentin; David Woolley; Craig Zwickl; Glenn J Myatt
Journal:  Comput Toxicol       Date:  2021-09-13

4.  Air-liquid interface cultures of the healthy and diseased human respiratory tract: promises, challenges and future directions.

Authors:  Domizia Baldassi; Bettina Gabold; Olivia Merkel
Journal:  Adv Nanobiomed Res       Date:  2021-05-06

5.  An In Vitro Lung System to Assess the Proinflammatory Hazard of Carbon Nanotube Aerosols.

Authors:  Hana Barosova; Bedia Begum Karakocak; Dedy Septiadi; Alke Petri-Fink; Vicki Stone; Barbara Rothen-Rutishauser
Journal:  Int J Mol Sci       Date:  2020-07-27       Impact factor: 5.923

6.  A Bioinspired in vitro Lung Model to Study Particokinetics of Nano-/Microparticles Under Cyclic Stretch and Air-Liquid Interface Conditions.

Authors:  Ali Doryab; Mehmet Berat Taskin; Philipp Stahlhut; Andreas Schröppel; Sezer Orak; Carola Voss; Arti Ahluwalia; Markus Rehberg; Anne Hilgendorff; Tobias Stöger; Jürgen Groll; Otmar Schmid
Journal:  Front Bioeng Biotechnol       Date:  2021-01-29

7.  A Custom-Made Device for Reproducibly Depositing Pre-metered Doses of Nebulized Drugs on Pulmonary Cells in vitro.

Authors:  Justus C Horstmann; Chelsea R Thorn; Patrick Carius; Florian Graef; Xabier Murgia; Cristiane de Souza Carvalho-Wodarz; Claus-Michael Lehr
Journal:  Front Bioeng Biotechnol       Date:  2021-04-21

8.  U.S. Federal Agency interests and key considerations for new approach methodologies for nanomaterials.

Authors:  Elijah J Petersen; Patricia Ceger; David G Allen; Jayme Coyle; Raymond Derk; Natalia Garcia-Reyero; John Gordon; Nicole C Kleinstreuer; Joanna Matheson; Danielle McShan; Bryant C Nelson; Anil K Patri; Penelope Rice; Liying Rojanasakul; Abhilash Sasidharan; Louis Scarano; Xiaoqing Chang
Journal:  ALTEX       Date:  2021-12-03       Impact factor: 6.250

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.